A doctor has identified four specific health markers that may predict the risk of heart attack and stroke before symptoms appear [1].
These markers provide a more comprehensive view of vascular health than traditional screenings. By identifying risks early, patients and providers can implement prevention strategies to reduce the likelihood of severe cardiovascular events [1].
The first marker is ApoB, which measures the number of atherogenic particles in the blood [1]. These particles contribute to the buildup of plaque in the arteries, increasing the risk of blockage [1].
High-sensitivity C-reactive protein, or hs-CRP, serves as the second marker [1]. This protein indicates systemic inflammation in the body, which is often linked to the instability of arterial plaques [1].
Insulin resistance is the third critical indicator [1]. When the body cannot effectively use insulin, it can lead to metabolic changes that damage the lining of the blood vessels [1].
Finally, the doctor said abdominal obesity is a primary marker [1]. Excess fat stored around the midsection is associated with higher levels of inflammation and metabolic dysfunction, both of which elevate cardiovascular risk [1].
Monitoring these four markers allows for a proactive approach to heart health [1]. Rather than waiting for symptomatic warnings, such as chest pain or shortness of breath, these tests can signal the need for lifestyle changes or medical intervention [1].
“Four health markers may predict heart-attack and stroke risk before symptoms appear.”
The shift toward measuring specific biomarkers like ApoB and hs-CRP represents a move toward precision medicine in cardiology. By focusing on the underlying drivers of arterial plaque and inflammation rather than just reacting to symptoms, healthcare providers can potentially identify high-risk individuals who would otherwise be missed by standard cholesterol tests.
